Pioneering a new class of therapeutics designed to activate progenitor cells Progenitor cells are similar to stem cells but are programmed to create specific cell types. These cells remain active and regenerate in some organs and tissues while becoming dormant in others. Frequency was founded in 2014 based on research by Professors Robert S. Langer at the Massachusetts Institute of Technology and Jeffrey Karp at Harvard Medical School. Their work focused on ways to activate the body’s regenerative potential, building on the insight that continuously activated progenitor cells in the gut regenerate the human intestinal lining every few days. Studying this biological process, they identified small molecules that could trigger the growth of new functional tissues and cells. Recognizing that similar progenitor cells were present but inactive in other organs, such as the cochlea within the ear, Professors Langer and Karp discovered how to adapt these natural signals and molecules to temporarily activate progenitor cells and create a localized healing response. Interested in joining our team? Explore careers © 2021 Frequency Therapeutics Open Positions Contact Privacy Policy Terms & Conditions

Leadership Frequency Therapeutics’ leadership team brings deep expertise in the development of innovative therapies and medical technologies. Our entrepreneurial team is dedicated to working collectively to develop a new category in regenerative medicine. David Lucchino Co-founder, President and CEO Chris Loose, PhD Co-founder and Chief Scientific Officer Carl LeBel, PhD Chief Development Officer Dana Hilt, MD Chief Medical Officer Wendy Arnold Chief People Officer Peter P. Pfreundschuh Chief Financial Officer Quentin McCubbin, PhD Chief Manufacturing Officer Susan Stewart, JD, LLM Chief Regulatory Officer Will McLean, PhD Co-founder and SVP, Hearing Biology and Translational Research Bill Chin, MD SVP, Translational Medicine Jason Glashow SVP, Corporate Affairs Kevin Franck, PhD SVP, Strategic Marketing and New Product Planning Lisa Geller, PhD, JD SVP, Intellectual Property Jeff Hrkach, PhD SVP, Technology Development Interested in joining our team? Explore careers © 2021 Frequency Therapeutics Open Positions Contact Privacy Policy Terms & Conditions